Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

ICAM-1/CD54 Antibody (1H4), PE, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NB11058732PE

Catalog No. NB1058732PE


Only null left
Add to Cart

Description

Description

ICAM-1/CD54 Monoclonal specifically detects ICAM-1/CD54 in Human samples. It is validated for Flow Cytometry, Flow (Cell Surface).
Specifications

Specifications

ICAM-1/CD54
Monoclonal
PE
PBS with 0.05% Sodium Azide
ICAM1
Raji cells and spleen cells fused with NS1 cells.
0.1 mL
Adaptive Immunity, Cancer, Cell Biology, Immunology, Mesenchymal Stem Cell Markers, Myeloid derived Suppressor Cell, Phospho Specific, Stem Cell Markers
3383
Human
Purified
Flow Cytometry
1H4
Flow Cytometry, Flow (Cell Surface)
BB2, CD54, CD54 antigen, cell surface glycoprotein P3.58, human rhinovirus receptor, ICAM-1, intercellular adhesion molecule 1, intercellular adhesion molecule 1 (CD54), human rhinovirus receptor, Major group rhinovirus receptor, P3.58
Mouse
Protein A purified
RUO
Primary
This antibody (clone 1H4) reacts with CD54 (ICAM-1), a 85-110 kDa type I transmembrane glycoprotein (receptor for rhinovirus) expressed on activated endothelial cells, T lymphocytes, B lymphocytes, monocytes, macrophages, granulocytes and dendritic cells; the expression of CD54 is upregulated by activation.
Store at 4C in the dark.
IgG2b
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.